TARDBP and Alzheimer disease: Current trials should take into consideration the significant evidence of multiple pathologies co-occurring with AD, including vascular brain injury, cerebral amyloid angiopathy (CAA), Lewy body pathology and TDP-43 inclusions [156–158].